Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text

Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

Journal of the American Academy of Dermatology
Volume 52, n° 3S
page P22 (mars 2005)
Doi : 10.1016/j.jaad.2004.10.101
Tazarotene versus tazarotene plus clindamycin/benzoyl peroxide in the treatment of acne vulgaris: A multicenter, double-blind, randomized, parallel-group trial

Alan Shalita, MD, State University of New York Downstate Medical Center, Brooklyn, NY, United States; Emil Tanghetti, MD, University of California at Davis, Sacramento, CA, United States; William Abramovits, MD, Baylor University Medical Center, Dallas, TX, United States; Barry Solomon, MD, Dermatique, Smithtown, NY, United States

Drs. Shalita and Tanghetti are consultants and investigators for Allergan, Inc. Drs. Abramovits and Solomon are investigators for Allergan, Inc.
Study supported by Allergan, Inc. Poster development supported by Stiefel Laboratories, Inc.

Top of the page

© 2005  American Academy of Dermatology, Inc.@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline
You can move this window by clicking on the headline